title: Genetic factors determine the contribution of leukotrienes to acute inflammatory responses.
abstract: Leukotrienes (LT) are potent lipid mediators synthesized by the 5-lipoxygenase pathway of arachidonic acid (AA) metabolism. LT have been implicated in a broad spectrum of inflammatory processes. To investigate the influence of genetic factors on the contribution of LT to acute inflammation, we generated congenic 5-lipoxygenase-deficient 129, C57BL/6 (B6), and DBA/1Lac (DBA) mouse lines. Topical application of AA evoked a vigorous inflammatory response in 129 and DBA mice, whereas only a modest response was seen in B6 animals. The response to AA in 129 and DBA strains is LT dependent. In contrast, LT make little contribution to this response in B6 mice. AA-induced inflammation in B6 mice is prostanoid dependent, since this response was substantially reduced by treating B6 mice with a cyclooxygenase inhibitor. These data suggest that prostanoids are essential for AA-induced cutaneous inflammation in B6 mice, whereas LT are the major mediators of this response in 129 and DBA strains. In contrast, the response to AA in the peritoneal cavity is robust in the 129 and B6 strains, but was significantly blunted in DBA mice, showing that strain differences in the response to AA are tissue specific. Variations in these and other experimental models of inflammation appear to correlate directly with the ability of a particular mouse strain and a specific tissue to respond to LT, specifically LTC4. Taken together, these findings indicate that the relative contribution of prostanoids and LT to inflammatory responses is variable not only between strains but also between different tissues within these inbred mouse lines.
authors.affiliation: Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Goulet
authors.forename: R S
authors.initials: RS
authors.lastname: Byrum
authors.forename: M L
authors.initials: ML
authors.lastname: Key
authors.forename: M
authors.initials: M
authors.lastname: Nguyen
authors.forename: V A
authors.initials: VA
authors.lastname: Wagoner
authors.forename: B H
authors.initials: BH
authors.lastname: Koller
mesh_terms: D000208:Acute Disease; D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000172:deficiency / Q000235:genetics; D016718:Arachidonic Acid / Q000633:toxicity; D003433:Crosses, Genetic; D004431:Ear, External; D004487:Edema / Q000139:chemically induced / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000201:enzymology / Q000235:genetics* / Q000503:physiopathology; D017997:Leukotriene C4 / Q000633:toxicity; D015289:Leukotrienes / Q000235:genetics* / Q000502:physiology; D051379:Mice; D020297:Mice, Congenic; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008817:Mice, Mutant Strains; D010538:Peritonitis / Q000139:chemically induced / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D013045:Species Specificity; D015054:Zymosan / Q000633:toxicity
chemical_list: D015289:Leukotrienes; D016718:Arachidonic Acid; D017997:Leukotriene C4; D015054:Zymosan; D001094:Arachidonate 5-Lipoxygenase; D007213:Indomethacin